• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Cerner Offers Free Access to De-Identified COVID-19 Patient Data for Research, Vaccine Development

Share:

April 28, 2020

Highlights on this story:
  • Cerner offers health systems and research centers free access to de-identified COVID-19 data to fight the COVID-19 pandemic.

  • The de-identified COVID-19 data includes patient demographics, underlying illnesses, chronic conditions, treatments, lab results, clinical complications and outcomes.

Today, Cerner announced a new offering to eligible U.S. health systems and academic research centers that it was providing complimentary access to critical de-identified COVID-19 patient data to help fight the pandemic.

The de-identified patient data secured and stored on Cerner HealtheDataLab, powered by Amazon Web Services Inc. (AWS), will include COVID-19-related demographics to help track spread and surge, underlying illnesses and chronic conditions, treatments, lab results, and clinical complications and outcomes that could help drive important medical decisions. A committee including Cerner associates and industry advisors has been established to review the applications and identify recipients that will benefit from the complimentary offering.

Impact of Leveraging De-Identified COVID-19 Data

“Cerner believes deeply in the power of clinical data to advance global research,” said Donald Trigg, president, Cerner. “The current COVID-19 pandemic compelled our team to develop a strategy to help leading health systems advance the search for critical solutions. When we ultimately move from crisis response to recovery, I am hopeful it will also demonstrate the promise of a ‘learning heath network’ to accelerate the next generation of discovery.”

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Prior to the COVID-19 pandemic, Cerner began working with research institutions to help clinicians more easily and efficiently gain health insights and guide care. Last year, Cerner announced the development of the Cerner Learning Health Network, piloting the program with Duke Clinical Research Institute. This work helps automate data collection from multiple sources, including the EHRs, to rapidly give medical researchers secure and compliant access to important information that has the potential to transform patient care.

Source: Hit Consultant

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Trump outlines new plan to lower Medicare drug  prices, end ‘rigged’ systemTrump outlines new plan to lower Medicare drug prices, end ‘rigged’ system
  • Technical Consulting is More Than Code: How I Lived the Uncommon Blend as a ConsultantTechnical Consulting is More Than Code: How I Lived the Uncommon Blend as a Consultant
  • CODA Biotherapeutics Acquires Attenua and Three Clinical Stage AssetsCODA Biotherapeutics Acquires Attenua and Three Clinical Stage Assets
  • Medirom Announces Partnership with MATRIX Industries to Deliver The World’s First Health Monitoring Wearable that Never Requires ChargingMedirom Announces Partnership with MATRIX Industries to Deliver The World’s First Health Monitoring Wearable that Never Requires Charging
  • Cressey & Company Acquires HealthDrive.Cressey & Company Acquires HealthDrive.
  • Globus Medical Completes Merger with NuVasiveGlobus Medical Completes Merger with NuVasive
  • Cerner Releases COVID-19 Reopening & Social Distancing Projections DashboardCerner Releases COVID-19 Reopening & Social Distancing Projections Dashboard
  • Nolato Acquires Us-based Medtech Manufacturer with Annual Sales of Approximately Sek 1.8 BillionNolato Acquires Us-based Medtech Manufacturer with Annual Sales of Approximately Sek 1.8 Billion

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications